Cargando…
Tumor Cells and Cancer-Associated Fibroblasts: A Synergistic Crosstalk to Promote Thyroid Cancer
Thyroid cancer is the most common endocrine malignancy. Although most thyroid cancer patients are successfully treated and have an excellent prognosis, a percentage of these patients will develop aggressive disease and, eventually, progress to anaplastic thyroid cancer. Since most patients with this...
Autores principales: | Fozzatti, Laura, Cheng, Sheue-yann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803596/ https://www.ncbi.nlm.nih.gov/pubmed/33161690 http://dx.doi.org/10.3803/EnM.2020.401 |
Ejemplares similares
-
Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression
por: Fozzatti, Laura, et al.
Publicado: (2019) -
Author Correction: Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression
por: Fozzatti, Laura, et al.
Publicado: (2019) -
Oncogenic Actions of the Nuclear Receptor Corepressor (NCOR1) in a Mouse Model of Thyroid Cancer
por: Fozzatti, Laura, et al.
Publicado: (2013) -
Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors
por: Zhu, Xuguang, et al.
Publicado: (2018) -
Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation()()
por: Zhu, Xuguang, et al.
Publicado: (2014)